Product Description
GENLISA™ Human SARS-CoV-2 (Covid-19) Spike Protein S1 Antigen Quantitative ELISA | KBVH015-10 | KRISHGEN BioSystems
Quantitative Determination of Human SARS-CoV-2 (Covid-19) spike S1 Protein serum, cell cuture supernatant and plasma.
This immunoassay quantitatively estimates the level of SARS-CoV-2 spike S1 protein in sampleMonoclonal antibodies are pre-coated onto microwells. Samples and standards are pipetted into microwells and Human SARS-CoV-2 (Covid-19) spike proteins present in the sample are bound by the capture antibodieSARS-CoV-2, a single stranded RNA virus, has quickly become the subject of much research worldwide. Coronaviruses are composed of four primary proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid (N). The spike protein (S-protein) performs two primary tasks that aid in host infection: 1) mediates the attachment between the virus and host cell surface receptors such as ACE2, and 2) facilitates viral entry into the host cell by assisting in the fusion of the viral and host cell membranes.